Ductal lavage in the high-risk patient

被引:4
作者
Francescatti, DS
Kluskens, L
Shah, L
机构
[1] Rush Univ, Med Ctr, Dept Surg, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA
关键词
breast cancer risk; ductal lavage;
D O I
10.1016/j.amjsurg.2004.11.018
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: This analysis was conducted in a single-surgeon clinical practice to evaluate the utility and practicality of performing ductal lavage in a population determined to be at high risk for breast cancer. Methods: One hundred twenty patients with negative mammograms and/or negative breast examinations had nipple aspiration and ductal lavage performed by a single surgeon. All were at high risk either according to Gail risk score, a previous breast carcinoma, or nipple discharge. Results: One hundred twenty patients underwent nipple aspiration. Thirty-two did not undergo lavage: 29 had no fluid, and 3 had unsuccessful cannulation. Eighty-eight underwent lavage: 15 had insufficient epithelial content, 51 had benign cytology, and 22 had abnormal cells. Of the 22, 20 had mild atypia, 1 had marked atypia, and 1 had malignant cells. Conclusions: Ductal lavage can be done in a surgical practice and can stratify risk for the individual patient. This is important to both patient and surgeon in formulating a treatment plan based on objective cytologic criteria. (c) 2005 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:340 / 341
页数:2
相关论文
共 2 条
[1]   Ductal lavage and the clinical management of women at high risk for breast carcinoma - A commentary [J].
O'Shaughnessy, JA ;
Ljung, BM ;
Dooley, WC ;
Chang, J ;
Kuerer, HM ;
Hung, DT ;
Grant, MD ;
Khan, SA ;
Phillips, RF ;
Duvall, K ;
Euhus, DM ;
King, BL ;
Anderson, BO ;
Troyan, SL ;
Kim, J ;
Veronesi, U ;
Cazzaniga, M .
CANCER, 2002, 94 (02) :292-298
[2]   Re: Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Vogel, VG ;
Costantino, JP ;
Wickerham, DL ;
Cronin, WM .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (19) :1504-1504